Cidara Therapeutics Inc (NASDAQ:CDTX)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - CDTX

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - CDTX

  • Market Cap$128.020m
  • SymbolNASDAQ:CDTX
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS1717571079

Company Profile

Cidara Therapeutics Inc is a biotechnology company. It is focused on the discovery, development, and commercialization of novel anti-infectives for the treatment and prevention of diseases. The company's main drug constitutes echinocandins antifungals in the form of CD101IV and CD101 topical. It has developed a proprietary immunotherapy technology platform, Cloudbreak, which is used to create compounds designed to direct a patient's immune cells to attack and eliminate pathogens that cause infectious diseases.Cidara Therapeutics Inc mainly develops anti-infective drugs in the United States. It attends to serious fungal infections through its drug candidates and proprietary immunotherapy technology platform, Cloudbreak.

Latest CDTX news

Currently there for this company. Visit our news hub for other news .